193 related articles for article (PubMed ID: 8873693)
1. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
Visser WH; Burggraaf J; Muller LM; Schoemaker RC; Fowler PA; Cohen AF; Ferrari MD
Clin Pharmacol Ther; 1996 Oct; 60(4):452-60. PubMed ID: 8873693
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
3. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
4. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
Prusiński A; Król F
Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
[TBL] [Abstract][Full Text] [Related]
7. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
8. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
10. Effect of subcutaneous sumatriptan on head temperature in migraines.
Parrinello G; Paterna S; Di Pasquale P; Pinto A; Cardinale A; Maniscalchi T; Cottone C; Follone G; Tuttolomondo A; Bologna P; Colomba D; D'Angelo A; Ortoleva A; Garofalo L; Piovana G; Capodieci E; Bova A; Giubilato A; Licata G
Drugs Exp Clin Res; 1998; 24(4):197-205. PubMed ID: 10051966
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
13. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
Tepper SJ; Cochran A; Hobbs S; Woessner M
Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients.
Maassen VanDenBrink A; Vergouwe MN; Ophoff RA; Naylor SL; Dauwerse HG; Saxena PR; Ferrari MD; Frants RR
Am J Med Genet; 1998 Jun; 77(5):415-20. PubMed ID: 9632173
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
Pini LA; Fabbri L; Cavazzuti L
Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
20. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
Salonen R; Ashford EA; Gibbs M; Hassani H
Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
